Sage Journals: Discover world-class research

Abstract

Herpes labialis are the most frequent clinical manifestations of HSV-1 infection. Epithelial cells are able to respond to HSV-1 presence inducing the expression of IL-6, IL-1, TNF-α and IL-8. These proinflammatory cytokines have a function in the acute-phase response mediation, chemotaxis, inflammatory cell activation and antigen-presenting cells. In the human epithelial cell models, it has been demonstrated that, after an early induction of proinflammatory host response, HSV-1 down-modulates the proinflammatory cytokine production through the accumulation of two viral proteins, ICP4 and ICP27, whose transcription is induced by tegument protein VP16. These viral proteins, through the decreasing of stabilizing the mRNAs of proinflammatory genes, delay cytokine production to an extent that allows the virus to replicate. Moreover, viral transactivating proteins, ICP-0 and VP-16 induce IL-10 expression. The conventional treatment of herpes labialis involves the topical and systemic use of antiviral drugs but it is necessary to find new therapies that can act in a selective and non-cytotoxic manner in viral infection. Laser diode therapy has been considered as a non-invasive alternative treatment to the conventional treatment of herpes labialis in pain therapy, in modulation of inflammation and in wound healing. This study aims to report a possible mechanism of action of laser diode irradiation in prevention and reduction of severity of labial manifestations of herpes labialis virus. We investigated, in an in vitro model of epithelial cells HaCat, the laser-effect on HSV-1 replication and we evaluated the modulation of expression of certain proinflammatory cytokines (TNF-α, IL-1β and IL-6), antimicrobial peptide HBD2, chemokine IL-8 and the immunosuppressive cytokine, IL-10. Our results lead us to hypothesize that LD-irradiation acts in the final stage of HSV-1 replication by limiting viral spread from cell to cell and that laser therapy acts also on the host immune response unblocking the suppression of proinflammatory mediators induced by accumulation of progeny virus in infected epithelial cells.

Keywords

Laser Diode Therapy HSV-1 proinflammatory cytokines

References

Whitley

Roizman

. Herpes simplex virus infections. Lancet 2001; 357:1513–8.

Roizman

Knipe

. Herpes simplex viruses and their replication. In: Fields virology. Knipe

and Howley

P. M.

, ed. Lippincott Williams & Wilkins, Philadelphia, 2001; p. 2399–459.

Nicola

Hou

Major

Straus

. Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway. J Virol 2005; 79:7609–16.

Mikloska

Danis

Adams

Lloyd

Adrian

Cunningham

. In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions - do herpes simplex virus-infected keratinocytes contribute to their production? J Infect Dis 1998; 177:827–38.

Amici

Rossi

Costanzo

Ciafrè

Marinari

Balsamo

Levrero

Santoro

. Herpes simplex virus disrupts NF-κB regulation by blocking its recruitment on the IκBα promoter and directing the factor on viral genes. J Biol Chem 2006; 281:7110–7.

Ayala

Grimaldi

Perfetto

Donnarumma

De Filippis

Donnarumma

Tufano

. 5-aminolaevulinic acid and photodynamic therapy reduce HSV-1 replication in HaCat cells through an apoptosis-independent mechanism. Photodermatol Photoimmunol Photomed 2008; 24:237–43.

Zhang

Kumar

Zheng

Atherton

. Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology 2006; 117:167–76.

Keadle

Usui

Laycock

Miller

Pepose

Stuart

. IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. Invest Ophthalmol Vis Sci 2000; 41:96–102.

Mogensen

Melchjorsen

Malmgaard

Casola

Paludan

. Suppression of proinflammatory cytokine expression by herpes simplex virus type 1. J Virol 2004; 78:5883–90.

10.

Zak-Prelich

Halliday

Walker

Yates

Norval

McKenzie

. Infection of murine keratinocytes with herpes simplex virus type 1 induces the expression of interleukin-10, but not interleukin-1 alpha or tumour necrosis factor-alpha. Immunology 2001; 104:468–75.

11.

Ganz

. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3:710–720.

12.

Dale

Fredericks

. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 2005; 7:119–33.

13.

Dommisch

Winter

Willebrand

. Immune regulatory functions of human beta-defensin-2 in odontoblast-like cells. Int Endod J 2007; 40:300–7.

14.

Kim

Min

Lee

Shin

Kim

. Effect of proinflammatory cytokines on the expression and regulation of human beta-defensin 2 in human dental pulp cells. J Endod 2010; 36:64–9.

15.

Kota

Sabbah

Chang

Harnack

Xiang

Meng

Bose

. Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus. J Biol Chem 2008; 283:22417–29.

16.

Arduino

Porter

. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med 2008; 37:107–21.

17.

Reusser

. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 1996; 33:235–48.

18.

Whitley

Kimberlin

Roizman

. Herpes simplex viruses. Clin Infect Dis 1998; 26:541–53.

19.

Bello-Silva

de Freitas

Aranha

Lage-Marques

Simões

de Paula Eduardo

. Low- and high-intensity lasers in the treatment of herpes simplex virus 1 infection. Photomed Laser Surg 2009; 28:135–9.

20.

Marotti

Sperandio

Fregnani

Aranha

de Freitas

de Paula Eduardo

. High-Intensity laser and photodynamic therapy as a treatment for recurrent herpes labialis. Photomed Laser Surg 2010; 28:439–44.

21.

Reddy

Stehno-Bittel

Enwemeka

. Laser photostimulation accelerates wound healing in diabetic rats. Wound Repair Regen 2001; 9:248–55.

22.

Hagiwara

Iwasaka

Okuda

Noguchi

. GaAlAs (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Lasers Surg Med 2007; 39:797–802.

23.

Chi

Nairn

Lanzafame

. Improvement of host response to sepsis by photobiomodulation. Lasers Surg Med 1997; 21:262–8.

24.

Simkin

Tao

Levy

Hunt

. IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy. J Immunol 2000; 164:2457–62.

25.

Wilson

Fakioglu

Herold

. Novel approaches in fighting herpes simplex virus infections. Expert Rev Anti Infect Ther 2009; 7:559–68.

26.

Boukamp

Petrussevska

Breitkreutz

Hornung

Markham

Fusenig

. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106:761–71.

27.

Khan

Ather

Thompson

Gambari

. Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res 2005; 36:1046–57.

28.

Túner

Hode

. The laser therapy handbook. ed Prima Books, Sweden 2007; p. 1.

29.

de Carvalho

de Paula Eduardo

Ramalho

Antunes

Bezinelli

de Magalhães

Pegoretti

de Freitas

de Paula Eduardo

. Effect of laser phototherapy on recurring herpes labialis prevention: an in vivo study. Lasers Med Sci 2010; 25:397–402.

30.

Qadri

Miranda

Tuner

Gustafsson

. The short-term effects of low-level lasers as adjunct therapy in the treatment of periodontal inflammation. J Clin Periodontal 2005; 32:714–9.

Inhibition of HSV-1 Replication by Laser Diode-Irradiation: Possible Mechanism of Action

Abstract

Keywords

References